Researchers from the Icahn School of Medicine at Mount Sinai will present their Late-Breaking Clinical Trial findings and other important research results advancing the field of cardiovascular medicine at the American College of Cardiology’s 65th Annual Scientific Session and Expo
Researchers are studying how marine mammals—which have naturally high levels of carbon monoxide—might shed light on the protective effects of carbon monoxide. The findings could help refine approaches for carbon monoxide-based therapies currently being tested in several ongoing clinical trials.
A new study shows that blocking the blood supply of small cell lung cancer tumors may help slow their growth and delay a rebound after chemotherapy. Small cell lung cancer is one of the most devastating forms of cancer and a significant cause of cancer deaths each year.
Just released two-year follow up data comparing coronary-artery bypass grafting (CABG) with combined CABG and mitral-value repair in patients with moderate ischemic mitral regurgitation (IMR) found no significant differences in benefit. The patients with CABG and mitral-valve repair had an early hazard of longer hospital stay post-surgery, a higher incidence of postoperative supraventricular arrhythmias and higher rate of serious neurological events than those with CABG alone.
A new multi-year study from the Intermountain Medical Center Heart Institute in Salt Lake City shows that testosterone therapy helped elderly men with low testosterone levels and pre-existing coronary artery disease reduce their risks of major adverse cardiovascular events — including strokes, heart attacks, and death.
A combined vaccine therapy including live Salmonella is a safe and effective way to prevent diabetes in mice and may point to future human therapies, a new study finds. The results will be on Sunday, April 3, at ENDO 2016, the annual meeting of the Endocrine Society, in Boston.
Young children who take antibiotics may disrupt their gut’s microbial ecosystem and be more likely to develop prediabetes in adolescence, new research from Greece reports. The study results will be presented in a poster Sunday, April 3, at ENDO 2016, the annual meeting of the Endocrine Society, in Boston.
Aromatase inhibitors, when used for up to three years in combination with growth hormone, may effectively and safely help very short adolescent boys grow taller, new research suggests. The study results will be presented Sunday, April 3, at ENDO 2016, the annual meeting of the Endocrine Society in Boston.
Despite guidelines that advocate the use of weight loss medications to treat obesity, and the availability of FDA approved medications, very few patients use this treatment option, a new study suggests. The results will be presented Sunday, April 3, at ENDO 2016, the annual meeting of the Endocrine Society, in Boston.
In obese middle-aged men, losing weight while dieting normally depletes both fat and muscle. But adding testosterone treatment may help them lose only fat and retain their muscle, new research suggests. The study results will be presented in a poster Saturday, April 2, at ENDO 2016, the annual meeting of the Endocrine Society, in Boston.
The investigational drug abaloparatide-SC (subcutaneous) may help increase bone mineral density in postmenopausal women and reduce their risk of fracture, new industry-sponsored research suggests. The results of the subgroup analysis within the ACTIVE clinical trial will be presented Friday, April 1, at ENDO 2016, the annual meeting of the Endocrine Society in Boston
Children and teenagers who take stimulant drugs to treat attention-deficit hyperactivity disorder (ADHD) may have lower bone density than their peers who do not take these medications, a new study finds. The study results will be presented Friday at the Endocrine Society’s 98th annual meeting in Boston.
Antidepressant use with selective serotonin reuptake inhibitors (SSRIs) during pregnancy and breast-feeding causes decreased bone density in mothers that may put them at higher risk of broken bones later in life, a new study suggests. Researchers will present the results of their animal study Friday at the Endocrine Society’s 98th annual meeting in Boston.
Findings from the early phase of a clinical trial led by Johns Hopkins investigators indicates that a new, minimally invasive weight loss treatment known as bariatric arterial embolization is safe and effective in sustaining weight loss in severely obese people.
Low levels of total vitamin D and bioavailable vitamin D can help predict a person’s risk of major adverse cardiovascular events such as a heart attack, stroke, heart failure or death, according to a first-of-its-kind study from the Intermountain Medical Center Heart Institute in Salt Lake City.
New study by researchers at the Intermountain Medical Center Heart Institute in Salt Lake City found that effectively treating depression can reduce a patient’s chance of having a stroke, heart failure, a heart attack or death.
People with high levels of good cholesterol, or high-density lipoprotein, are not as safe from heart disease when high levels of a newly identified biomarker of inflammation in the arteries are also found in their bloodstream, according to a new study.
A new low-dose vaginal estrogen capsule may help relieve symptoms of menopausal vulvar and vaginal atrophy, including dyspareunia (pain during sex), new industry-sponsored research reports. The study results will be presented in a late-breaking poster Saturday, April 2, at ENDO 2016, the annual meeting of the Endocrine Society, in Boston.
New research suggests pretreating cells with a peptide hormone may improve the success rate of pancreatic islet cell transplants, a procedure that holds great promise for curing Type 1 diabetes. The results will be presented Saturday, April 2, at the Endocrine Society’s annual meeting, ENDO 2016, in Boston.
Among reproductive-age women, polycystic ovary syndrome (PCOS) as well as overweight and obesity are independently linked with asthma, new preliminary research from Australia suggests. The results will be presented in a poster Saturday, April 2, at ENDO 2016, the annual meeting of the Endocrine Society, in Boston.
Brominated fire retardants, used in many consumer products and known to cause hormonal irregularities, overstimulates an adrenal gland hormone in a way that may lead to the development of cardiovascular disease, new research in human cells finds. Researchers will present their study results Saturday at the Endocrine Society’s 98th annual meeting in Boston.
Anabolic androgenic steroid (AAS) abuse is associated with severe blood pressure (BP) increase and hypertension, new research reports. The results of the study will be presented in a poster Saturday, April 2, at ENDO 2016, the annual meeting of the Endocrine Society, in Boston.
A study in military veterans finds that explosive blast-related concussions frequently result in hormone changes leading to problems such as sleep disturbances, fatigue, depression and poor quality of life. The research, to be presented Saturday at the Endocrine Society’s 98th annual meeting in Boston, evaluated hormone levels in 41 male veterans who had been deployed to Iraq or Afghanistan.
Researchers are exploring one possible physiologic explanation of why prior studies have demonstrated a higher risk of breast cancer in women who experience high levels of illumination at night. Their study results in an animal model will be presented Saturday at the Endocrine Society’s 98th annual meeting in Boston.
In young female athletes who stop having their menstrual periods because of excessive exercise, estrogen replacement appears to improve their memory, a new study finds. Researchers will present their study results on Saturday at the Endocrine Society’s 98th annual meeting in Boston.
Steroid medications inhibit the activity of brown fat, which is the “good,” calorie-burning fat humans and animals have, Australian researchers have discovered. They will present their study findings Saturday at the Endocrine Society’s 98th annual meeting in Boston.
Anti-Mullerian hormone (AMH) blood levels may provide a useful biomarker for the diagnosis and treatment of polycystic ovary syndrome (PCOS) in obese adolescent girls, new research suggests. The results will be presented Saturday, April 2, at ENDO 2016, the annual meeting of the Endocrine Society, in Boston.
A single dose of oxytocin nasal spray, known to reduce food intake, decreases impulsive behavior in overweight and obese men, according to a preliminary study to be presented Saturday at the Endocrine Society’s 98th annual meeting in Boston.
Women of reproductive age who have thyroid cancer should be cautious about receiving radioactive iodine treatment, which affects their remaining egg supply – their ovarian reserve – and may affect their fertility, new research from Israel finds. The results of this ongoing study will be presented Saturday, April 2, at ENDO 2016, the annual meeting of the Endocrine Society in Boston.
In older people, higher dietary calcium intake may lower the risk of cardiovascular disease, but not of stroke and fracture, new research from South Korea suggests. The results will be presented in a poster Saturday, April 2, at ENDO 2016, the annual meeting of the Endocrine Society, in Boston.
Combining a temporary one-year intestinal bypass device with the drug liraglutide helps patients lose weight and improve their diabetes control better than using either the device or the drug alone, new research from the United Kingdom reports. The one-year results of the two-year study will be presented in a poster Saturday, April 2, at ENDO 2016, the annual meeting of the Endocrine Society in Boston.
Most people lose, gain and maintain their weight inconsistently, and those who lose the most weight are most likely to keep it off and keep losing, new research reports. The study results will be presented Friday, April 1, at ENDO 2016, the annual meeting of the Endocrine Society, in Boston.
Pediatricians can now identify infants who are at higher risk of early-childhood obesity, before obesity develops, using a simple measurement of body mass index (BMI), a tool not routinely used until children are 2 years old. This conclusion, from a new study of nearly 4,000 children, will be presented Friday at the Endocrine Society’s 98th annual meeting in Boston.
A Paleolithic-type diet may help obese postmenopausal women lose weight, improve their circulating fatty acid profile and lower their future risk for diabetes and cardiovascular disease, new research reports. The study results will be presented in a poster Sunday, April 3, at ENDO 2016, the annual meeting of the Endocrine Society, in Boston.
A new study finds that the diabetes drug liraglutide leads to weight loss by acting on an area of the brain that controls attention and possibly making desirable foods less rewarding. Researchers will present their results Saturday at the Endocrine Society’s 98th annual meeting in Boston.
A large breakfast containing whey protein may help manage Type 2 diabetes, new research from Israel reports. The study results will be presented Friday, April 1, at ENDO 2016, the annual meeting of the Endocrine Society, in Boston.
Having too little thyroid hormone in the blood—even in the low-normal range—raises the risk of developing Type 2 diabetes, especially in people with prediabetes, a new study in nearly 8,500 people finds. The study results will be presented Sunday at the Endocrine Society’s 98th annual meeting in Boston.
A new study from Intermountain Medical Center Heart Institute and Johns Hopkins Medical Center lends more evidence to the idea that it’s better to be shaped like a pear — with weight around the hips — as opposed to an apple — with weight around the abdomen.
Use of a common nonprescription antimicrobial, triclocarban (TCC), during pregnancy and breast-feeding may alter the offspring’s composition of intestinal bacteria and other micro-organisms, called the gut microbiota, a new animal study finds. Presentation of the results will take place Friday at the Endocrine Society’s 98th annual meeting in Boston.
A new culture system that tests the role of chemical exposure on the developing mammary gland has found that bisphenol A (BPA) directly affects the mammary gland of mouse embryos. The study results, to be presented Friday at the Endocrine Society’s 98th annual meeting in Boston, show that these changes to embryonic mammary tissue occur at a dose comparable to that of humans’ environmental exposure to BPA.
Children who are often hospitalized in intensive care units are more likely to have attention deficit disorders later, and new research finds a possible culprit: a high level of plastic-softening chemicals called phthalates circulating in the blood. The researchers, who will present their study results Friday at the Endocrine Society’s 98th annual meeting in Boston, suggest these chemicals, which are added to indwelling medical devices such as plastic tubes and catheters, seep into the child’s bloodstream.
Many ultraviolet (UV)-filtering chemicals commonly used in sunscreens interfere with the function of human sperm cells, and some mimic the effect of the female hormone progesterone, a new study finds. Results of the Danish study will be presented Friday at the Endocrine Society’s 98th annual meeting in Boston.
Kaiser Health News Senior Correspondent Julie Rovner received the Endocrine Society’s annual Award for Excellence in Science and Medical Journalism, the Society announced today.
Elderly adults are bigger around the middle when they turn up the heat inside their homes during the cold season and have smaller waistlines when their homes stay cool, new research finds. Investigators from Japan will present their study results Friday at the Endocrine Society’s 98th annual meeting in Boston.
A new study of African-American infants finds that those who feed more vigorously at 1 month of age have higher weight at 4 months, which may be associated with a later risk for obesity. Researchers will present their study findings Friday at the Endocrine Society’s 98th annual meeting in Boston.
Higher levels of blood markers in the umbilical cord indicate that the baby has more fat and may continue having more fat into late childhood and adolescence, new research suggests. The results will be presented in a poster Friday, April 1, at ENDO 2016, the annual meeting of the Endocrine Society in Boston.
Among military veterans identifying as transgender, 90 percent have at least one mental health diagnosis, such as posttraumatic stress disorder (PTSD) or depression, and nearly 50 percent had a hospitalization after a suicide attempt or suicidal thoughts. These study findings, from a single veterans’ hospital, will be presented Friday at The Endocrine Society’s 98th annual meeting in Boston.
Lifestyle changes that include healthier diet and routine physical exercise help older overweight and obese adults with Type 2 diabetes improve glucose control, body composition, physical function and bone quality, according to preliminary findings of an ongoing clinical trial. The six-month results of the one-year study will be presented Friday, April 1, at ENDO 2016, the annual meeting of the Endocrine Society, in Boston.
Doctors have devised a test which could help them predict which women going through menopause will lose bone faster than average, new research reports. The results of the study will be presented Friday, April 1, at ENDO 2016, the annual meeting of the Endocrine Society, in Boston.
In mildly obese (“class I”) patients, sleeve with ileal transposition (sleeve-IT) surgery results in better glycemic control than either gastric bypass or clinical treatment, a new study from Brazil suggests. The results will be presented Friday, April 1, at ENDO 2016, the annual meeting of the Endocrine Society, in Boston.
RSS
Medicine keyboard_arrow_right
Sciencekeyboard_arrow_right
Life keyboard_arrow_right
Business keyboard_arrow_right
Journal News keyboard_arrow_right
By Location keyboard_arrow_right
Meetings, Grants, and Events keyboard_arrow_right